The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 381,945 | $30.41M |
| Grant or award | 7 | 10,710 | |
| Option exercise | 4 | 60,000 | |
| Tax withholding / forfeiture | 3 | 32,403 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
167 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Tax withholding / forfeiture | Common Stock | 10,801 | $65.21 | $704K | ||
| Tax withholding / forfeiture | Common Stock | 10,801 | $65.21 | $704K | ||
| Jane Prior - Officer | Tax withholding / forfeiture | Common Stock | 10,801 | $65.21 | $704K | |
| Open-market sale | Common Stock | 3,900 | $82.92 | $323K | ||
| Open-market sale | Common Stock | 74,232 | $80.29 | $5.96M | ||
| Open-market sale | Common Stock | 73,842 | $80.32 | $5.93M | ||
| Open-market sale | Common Stock | 95,768 | $79.14 | $7.58M | ||
| Open-market sale | Common Stock | 96,158 | $79.14 | $7.61M | ||
| Option exercise | Common Stock | 23,575 | $10.18 | $240K | ||
| Option exercise | Common Stock | 6,425 | $10.18 | $65K | ||
| Open-market sale | Common Stock | 30,000 | $80.00 | $2.40M | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 23,575 | $0.00 | - | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 6,425 | $0.00 | - | ||
| Grant or award | Common Stock | 1,530 | $75.18 | $115K | ||
| Grant or award | Common Stock | 1,530 | $75.18 | $115K | ||
| Grant or award | Common Stock | 1,530 | $75.18 | $115K | ||
| Aishetu Fatima Dozie - Director | Grant or award | Common Stock | 1,530 | $75.18 | $115K | |
| John Zupo - Director | Grant or award | Common Stock | 1,530 | $75.18 | $115K | |
| Grant or award | Common Stock | 1,530 | $75.18 | $115K | ||
| Eric Melloul - Director | Grant or award | Common Stock | 1,530 | $75.18 | $115K | |
| Open-market sale | Common Stock | 8,045 | $75.05 | $604K | ||
| Open-market sale | Common Stock | 3,900 | $77.48 | $302K | ||
| Option exercise | Common Stock | 30,000 | $10.18 | $305K | ||
| Open-market sale | Common Stock | 30,000 | $75.00 | $2.25M | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 30,000 | $0.00 | - | ||
| Option exercise | Common Stock | 20,000 | $10.18 | $204K | ||
| Open-market sale | Common Stock | 20,000 | $70.00 | $1.40M | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 20,000 | $0.00 | - | ||
| Open-market sale | Common Stock | 8,561 | $70.00 | $599K | ||
| Open-market sale | Common Stock | 2,000 | $66.87 | $134K | ||
| Michael Kirban - Officer | Open-market sale | Common Stock | 50,000 | $68.00 | $3.40M | |
| Option exercise | Common Stock | 20,000 | $10.18 | $204K | ||
| Option exercise | Common Stock | 20,000 | $10.18 | $204K | ||
| Option exercise | Common Stock | 20,000 | $10.18 | $204K | ||
| Open-market sale | Common Stock | 20,000 | $65.00 | $1.30M | ||
| Open-market sale | Common Stock | 20,000 | $62.50 | $1.25M | ||
| Open-market sale | Common Stock | 20,000 | $67.50 | $1.35M | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 20,000 | $0.00 | - | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 20,000 | $0.00 | - | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 20,000 | $0.00 | - | ||
| Option exercise | Common Stock | 25,000 | $10.18 | $254K | ||
| Option exercise | Common Stock | 25,000 | $10.18 | $254K | ||
| Open-market sale | Common Stock | 25,000 | $50.00 | $1.25M | ||
| Open-market sale | Common Stock | 25,000 | $50.00 | $1.25M | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | - | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | - | ||
| Option exercise | Common Stock | 25,000 | $10.18 | $254K | ||
| Open-market sale | Common Stock | 25,000 | $50.00 | $1.25M | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | - | ||
| Option exercise | Common Stock | 25,000 | $10.18 | $254K | ||
| Option exercise | Common Stock | 25,000 | $10.18 | $254K | ||
| Open-market sale | Common Stock | 25,000 | $50.00 | $1.25M | ||
| Open-market sale | Common Stock | 25,000 | $50.11 | $1.25M | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | - | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | - | ||
| Open-market sale | Common Stock | 3,900 | $48.93 | $191K | ||
| Option exercise | Common Stock | 25,000 | $10.18 | $254K | ||
| Open-market sale | Common Stock | 25,000 | $50.11 | $1.25M | ||
| Option exercise | Common Stock | 4,456 | $10.18 | $45K | ||
| Open-market sale | Common Stock | 4,456 | $50.55 | $225K | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | - | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 4,456 | $0.00 | - | ||
| Option exercise | Common Stock | 25,000 | $10.18 | $254K | ||
| Option exercise | Common Stock | 25,000 | $10.18 | $254K | ||
| Open-market sale | Common Stock | 25,000 | $50.00 | $1.25M | ||
| Open-market sale | Common Stock | 25,000 | $50.95 | $1.27M | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | - | ||
| Option exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | - | ||
| Open-market sale | Common Stock | 2,000 | $48.67 | $97K | ||
| Corey Baker - Officer | Open-market sale | Common Stock | 2,000 | $55.45 | $111K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Vita Coco Company, Inc. (COCO) had 15 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for COCO runs to 167 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of COCO were filed in the last 90 days.
7 insider sales of COCO were filed in the last 90 days, totaling $30.41M.
This page tracks COCO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add COCO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.